17 Jun 2026Open access
Neurobehavioural Effects of the Methylimidazolium Ionic Liquid M8OI in RatsPublisher siteJournal of Xenobiotics, Ionic liquids properties and applications
UniversitiesSherehan M. Ibrahim
Active, last published 2026
In parkinson's disease mechanisms and treatments
Sherehan M.
Ibrahim
Scholar“Research focused on Parkinson's Disease Mechanisms and Treatments and adjacent fields.”
Cairo University
Claim Your Profile14
H-index
549
Citations
Sherehan has not officially claimed their profile. If you are Sherehan, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
herehan M. Ibrahim is a researcher working on Parkinson's Disease Mechanisms and Treatments. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Sherehan's work has been cited 549 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Parkinson's Disease Mechanisms and Treatments×3COVID-19 Clinical Research Studies×2SARS-CoV-2 and COVID-19 Research×2Liver Disease Diagnosis and Treatment×2Genomics, phytochemicals, and oxidative stress×2
04 · Where I am
Affiliations
Affiliation on published researchCairo UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
6 works27 Mar 2026
Renoprotective effects of DAPT against zymosan-induced acute kidney injury and senescence: Unraveling the role of toll like receptor 2 and Notch1 signaling pathways through an integrated in vivo and in silico analysisPublisher siteEuropean Journal of Pharmacology, Acute Kidney Injury Research
16 Dec 2025
Empagliflozin beyond antidiabetic effect: Amelioration of cyclophosphamide-induced testicular toxicity in rats: Orchestrating klotho/Nrf-2/PPAR-γ/NF-κB/Bax/Bcl-2 cuesPublisher siteBiochemical Pharmacology, Chemotherapy-induced organ toxicity mitigation
1 Nov 2025Open access1cites
Bromelain Alleviates 3‐Nitropropionic Acid‐Induced Huntington's Disease‐Like Symptoms in Rats Through the Interplay of <scp>SIRT1</scp> / <scp>PGC</scp> ‐1α and <scp>FOXO3a</scp> PathwaysPublisher siteBioFactors, Sirtuins and Resveratrol in Medicine
17 May 2025Open access3cites
Limettin and PD98059 Mitigated Alzheimer’s Disease Like Pathology Induced by Streptozotocin in Mouse Model: Role of p-ERK1/2/p-GSK-3β/p-CREB/BDNF PathwayPublisher siteJournal of Neuroimmune Pharmacology, Cholinesterase and Neurodegenerative Diseases
29 Jul 202421cites
Canagliflozin Mitigated Cognitive Impairment in Streptozotocin-Induced Sporadic Alzheimer’s Disease in Mice: Role of AMPK/SIRT-1 Signaling Pathway in Modulating NeuroinflammationPublisher siteJournal of Neuroimmune Pharmacology, Alzheimer's disease research and treatments
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Sherehan?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you